(Q42482003)

1 November 2017

title

Differential expression of perlecan receptors, α-dystroglycan and integrin β1, before and after invasion of oral squamous cell carcinoma (English)

1 reference

1 November 2017

Md Shahidul Ahsan

1

1 reference

1 November 2017

Manabu Yamazaki

2

1 reference

1 November 2017

Satoshi Maruyama

3

1 reference

1 November 2017

Takanori Kobayashi

4

1 reference

1 November 2017

Hiroko Ida-Yonemochi

5

1 reference

1 November 2017

Mayumi Hasegawa

6

1 reference

1 November 2017

Adeola Henry Ademola

7

1 reference

1 November 2017

Jun Cheng

8

1 reference

1 November 2017

Takashi Saku

9

1 reference

1 November 2017

language of work or name

1 reference

30 December 2010

1 reference

Journal of Oral Pathology & Medicine

1 November 2017

published in

1 reference

1 November 2017

volume

40

1 reference

1 November 2017

issue

7

1 reference

1 November 2017

page(s)

552-559

1 reference

Intraepithelial expression of perlecan, a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Histopathological varieties of oral carcinoma in situ: Diagnosis aided by immunohistochemistry dealing with the second basal cell layer as the proliferating center of oral mucosal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Perlecan, a basement membrane-type heparan sulfate proteoglycan, in the enamel organ: its intraepithelial localization in the stellate reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Perlecan: how does one molecule do so many things?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Basement membrane proteoglycans: from cellar to ceiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Establishment and characterization of pleomorphic adenoma cell systems: an in-vitro demonstration of carcinomas arising secondarily from adenomas in the salivary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Keratinocyte growth factor colocalized with perlecan at the site of capsular invasion and vascular involvement in salivary pleomorphic adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Diverse cell signaling events modulated by perlecan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Integrins in morphogenesis and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

The dystroglycan complex: from biology to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Dystroglycan binding to laminin alpha1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Analysis of heparin, alpha-dystroglycan and sulfatide binding to the G domain of the laminin alpha1 chain by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Two-phase appearance of oral epithelial dysplasia resulting from focal proliferation of parabasal cells and apoptosis of prickle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Important role of integrins in the cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

Integrins and dystroglycan regulate astrocyte wound healing: the integrin beta1 subunit is necessary for process extension and orienting the microtubular network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2010.00990.X

10.1111/J.1600-0714.2010.00990.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference